FILAMENT HEALTH ANNOUNCES UPSIZING AND CLOSING OF $2,500,000 NON-BROKERED PRIVATE PLACEMENT FINANCING

Financing led by psychedelic investment fund Negev Capital VANCOUVER, BC, July 24, 2023 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company”), a clinical-stage natural psychedelic drug development company, is pleased to announce an increase in the size of its previously announced private placement offering and that, further to its news release dated July…

Source